 | • レポートコード：MRC23Q35853 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、80ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のヤギ関節炎脳炎治療市場について調査・分析し、世界のヤギ関節炎脳炎治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（非化膿性白質脳脊髄炎（子ヤギ）、非化膿性関節炎・滑膜炎（大人ヤギ））、用途別セグメント分析（小売薬局、オンライン薬局、動物病院薬局、ドラッグストア）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Dechra Pharmaceuticals PLC、Zoetis Services LLC、Alivira Animal Health Limited、MSD Animal Health、Carus laboratories pvt. Ltd、Ceva Animal Health, LLC、Norbrook、Patterson vetsupply Inc.などが含まれています。世界のヤギ関節炎脳炎治療市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ヤギ関節炎脳炎治療市場規模を推定する際に考慮しました。本レポートは、ヤギ関節炎脳炎治療の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ヤギ関節炎脳炎治療に関するビジネス上の意思決定に役立てることを目的としています。 ・ヤギ関節炎脳炎治療市場の概要 - ヤギ関節炎脳炎治療のタイプ別セグメント - 世界のヤギ関節炎脳炎治療市場規模：タイプ別分析（非化膿性白質脳脊髄炎（子ヤギ）、非化膿性関節炎・滑膜炎（大人ヤギ）） - ヤギ関節炎脳炎治療の用途別セグメント - 世界のヤギ関節炎脳炎治療市場規模：用途別分析（小売薬局、オンライン薬局、動物病院薬局、ドラッグストア） - 世界のヤギ関節炎脳炎治療市場規模予測（2018年-2029年） ・ヤギ関節炎脳炎治療市場の成長トレンド - ヤギ関節炎脳炎治療の地域別市場規模（2018年-2029年） - ヤギ関節炎脳炎治療市場ダイナミクス - ヤギ関節炎脳炎治療の業界動向 - ヤギ関節炎脳炎治療市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：非化膿性白質脳脊髄炎（子ヤギ）、非化膿性関節炎・滑膜炎（大人ヤギ） - 世界のヤギ関節炎脳炎治療のタイプ別市場規模（2018年-2023年） - 世界のヤギ関節炎脳炎治療のタイプ別市場規模（2024年-2029年） ・用途別セグメント：小売薬局、オンライン薬局、動物病院薬局、ドラッグストア - 世界のヤギ関節炎脳炎治療の用途別市場規模（2018年-2023年） - 世界のヤギ関節炎脳炎治療の用途別市場規模（2024年-2029年） ・ヤギ関節炎脳炎治療の地域別市場規模 - 北米のヤギ関節炎脳炎治療市場規模（2018年-2029年） - アメリカのヤギ関節炎脳炎治療市場規模（2018年-2029年） - ヨーロッパのヤギ関節炎脳炎治療市場規模（2018年-2029年） - アジア太平洋のヤギ関節炎脳炎治療市場規模（2018年-2029年） - 中国のヤギ関節炎脳炎治療市場規模（2018年-2029年） - 日本のヤギ関節炎脳炎治療市場規模（2018年-2029年） - 韓国のヤギ関節炎脳炎治療市場規模（2018年-2029年） - インドのヤギ関節炎脳炎治療市場規模（2018年-2029年） - オーストラリアのヤギ関節炎脳炎治療市場規模（2018年-2029年） - 中南米のヤギ関節炎脳炎治療市場規模（2018年-2029年） - 中東・アフリカのヤギ関節炎脳炎治療市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Dechra Pharmaceuticals PLC、Zoetis Services LLC、Alivira Animal Health Limited、MSD Animal Health、Carus laboratories pvt. Ltd、Ceva Animal Health, LLC、Norbrook、Patterson vetsupply Inc. ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Caprine Arthritis Encephalitis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Caprine Arthritis Encephalitis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Caprine Arthritis Encephalitis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Caprine Arthritis Encephalitis Treatment in Retail Pharmacy is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Caprine Arthritis Encephalitis Treatment include Dechra Pharmaceuticals PLC, Zoetis Services LLC, Alivira Animal Health Limited, MSD Animal Health, Carus laboratories pvt. Ltd, Ceva Animal Health, LLC, Norbrook and Patterson vetsupply Inc., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Caprine Arthritis Encephalitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Caprine Arthritis Encephalitis Treatment.
The Caprine Arthritis Encephalitis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Caprine Arthritis Encephalitis Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Caprine Arthritis Encephalitis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Dechra Pharmaceuticals PLC
Zoetis Services LLC
Alivira Animal Health Limited
MSD Animal Health
Carus laboratories pvt. Ltd
Ceva Animal Health, LLC
Norbrook
Patterson vetsupply Inc.
Segment by Type
Nonsuppurative Leukoencephalomyelitis (in Young Goats)
Nonsuppurative Arthritis-Synovitis (in Adult Goats)
Segment by Application
Retail Pharmacy
Online Pharmacy
Veterinary Hospital Pharmacy
Drug Stores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Caprine Arthritis Encephalitis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Caprine Arthritis Encephalitis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Nonsuppurative Leukoencephalomyelitis (in Young Goats)
1.2.3 Nonsuppurative Arthritis-Synovitis (in Adult Goats)
1.3 Market by Application
1.3.1 Global Caprine Arthritis Encephalitis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Retail Pharmacy
1.3.3 Online Pharmacy
1.3.4 Veterinary Hospital Pharmacy
1.3.5 Drug Stores
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Caprine Arthritis Encephalitis Treatment Market Perspective (2018-2029)
2.2 Caprine Arthritis Encephalitis Treatment Growth Trends by Region
2.2.1 Global Caprine Arthritis Encephalitis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Caprine Arthritis Encephalitis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Caprine Arthritis Encephalitis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Caprine Arthritis Encephalitis Treatment Market Dynamics
2.3.1 Caprine Arthritis Encephalitis Treatment Industry Trends
2.3.2 Caprine Arthritis Encephalitis Treatment Market Drivers
2.3.3 Caprine Arthritis Encephalitis Treatment Market Challenges
2.3.4 Caprine Arthritis Encephalitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Caprine Arthritis Encephalitis Treatment Players by Revenue
3.1.1 Global Top Caprine Arthritis Encephalitis Treatment Players by Revenue (2018-2023)
3.1.2 Global Caprine Arthritis Encephalitis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Caprine Arthritis Encephalitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Caprine Arthritis Encephalitis Treatment Revenue
3.4 Global Caprine Arthritis Encephalitis Treatment Market Concentration Ratio
3.4.1 Global Caprine Arthritis Encephalitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Caprine Arthritis Encephalitis Treatment Revenue in 2022
3.5 Caprine Arthritis Encephalitis Treatment Key Players Head office and Area Served
3.6 Key Players Caprine Arthritis Encephalitis Treatment Product Solution and Service
3.7 Date of Enter into Caprine Arthritis Encephalitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Caprine Arthritis Encephalitis Treatment Breakdown Data by Type
4.1 Global Caprine Arthritis Encephalitis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Caprine Arthritis Encephalitis Treatment Forecasted Market Size by Type (2024-2029)
5 Caprine Arthritis Encephalitis Treatment Breakdown Data by Application
5.1 Global Caprine Arthritis Encephalitis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Caprine Arthritis Encephalitis Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Caprine Arthritis Encephalitis Treatment Market Size (2018-2029)
6.2 North America Caprine Arthritis Encephalitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Caprine Arthritis Encephalitis Treatment Market Size by Country (2018-2023)
6.4 North America Caprine Arthritis Encephalitis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Caprine Arthritis Encephalitis Treatment Market Size (2018-2029)
7.2 Europe Caprine Arthritis Encephalitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Caprine Arthritis Encephalitis Treatment Market Size by Country (2018-2023)
7.4 Europe Caprine Arthritis Encephalitis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Caprine Arthritis Encephalitis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Caprine Arthritis Encephalitis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Caprine Arthritis Encephalitis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Caprine Arthritis Encephalitis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Caprine Arthritis Encephalitis Treatment Market Size (2018-2029)
9.2 Latin America Caprine Arthritis Encephalitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Caprine Arthritis Encephalitis Treatment Market Size by Country (2018-2023)
9.4 Latin America Caprine Arthritis Encephalitis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Caprine Arthritis Encephalitis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Caprine Arthritis Encephalitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Caprine Arthritis Encephalitis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Caprine Arthritis Encephalitis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Dechra Pharmaceuticals PLC
11.1.1 Dechra Pharmaceuticals PLC Company Detail
11.1.2 Dechra Pharmaceuticals PLC Business Overview
11.1.3 Dechra Pharmaceuticals PLC Caprine Arthritis Encephalitis Treatment Introduction
11.1.4 Dechra Pharmaceuticals PLC Revenue in Caprine Arthritis Encephalitis Treatment Business (2018-2023)
11.1.5 Dechra Pharmaceuticals PLC Recent Development
11.2 Zoetis Services LLC
11.2.1 Zoetis Services LLC Company Detail
11.2.2 Zoetis Services LLC Business Overview
11.2.3 Zoetis Services LLC Caprine Arthritis Encephalitis Treatment Introduction
11.2.4 Zoetis Services LLC Revenue in Caprine Arthritis Encephalitis Treatment Business (2018-2023)
11.2.5 Zoetis Services LLC Recent Development
11.3 Alivira Animal Health Limited
11.3.1 Alivira Animal Health Limited Company Detail
11.3.2 Alivira Animal Health Limited Business Overview
11.3.3 Alivira Animal Health Limited Caprine Arthritis Encephalitis Treatment Introduction
11.3.4 Alivira Animal Health Limited Revenue in Caprine Arthritis Encephalitis Treatment Business (2018-2023)
11.3.5 Alivira Animal Health Limited Recent Development
11.4 MSD Animal Health
11.4.1 MSD Animal Health Company Detail
11.4.2 MSD Animal Health Business Overview
11.4.3 MSD Animal Health Caprine Arthritis Encephalitis Treatment Introduction
11.4.4 MSD Animal Health Revenue in Caprine Arthritis Encephalitis Treatment Business (2018-2023)
11.4.5 MSD Animal Health Recent Development
11.5 Carus laboratories pvt. Ltd
11.5.1 Carus laboratories pvt. Ltd Company Detail
11.5.2 Carus laboratories pvt. Ltd Business Overview
11.5.3 Carus laboratories pvt. Ltd Caprine Arthritis Encephalitis Treatment Introduction
11.5.4 Carus laboratories pvt. Ltd Revenue in Caprine Arthritis Encephalitis Treatment Business (2018-2023)
11.5.5 Carus laboratories pvt. Ltd Recent Development
11.6 Ceva Animal Health, LLC
11.6.1 Ceva Animal Health, LLC Company Detail
11.6.2 Ceva Animal Health, LLC Business Overview
11.6.3 Ceva Animal Health, LLC Caprine Arthritis Encephalitis Treatment Introduction
11.6.4 Ceva Animal Health, LLC Revenue in Caprine Arthritis Encephalitis Treatment Business (2018-2023)
11.6.5 Ceva Animal Health, LLC Recent Development
11.7 Norbrook
11.7.1 Norbrook Company Detail
11.7.2 Norbrook Business Overview
11.7.3 Norbrook Caprine Arthritis Encephalitis Treatment Introduction
11.7.4 Norbrook Revenue in Caprine Arthritis Encephalitis Treatment Business (2018-2023)
11.7.5 Norbrook Recent Development
11.8 Patterson vetsupply Inc.
11.8.1 Patterson vetsupply Inc. Company Detail
11.8.2 Patterson vetsupply Inc. Business Overview
11.8.3 Patterson vetsupply Inc. Caprine Arthritis Encephalitis Treatment Introduction
11.8.4 Patterson vetsupply Inc. Revenue in Caprine Arthritis Encephalitis Treatment Business (2018-2023)
11.8.5 Patterson vetsupply Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details